Actively Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Led by Duke University · Updated on 2026-04-08
420
Participants Needed
6
Research Sites
74 weeks
Total Duration
On this page
Sponsors
D
Duke University
Lead Sponsor
B
Bayer
Collaborating Sponsor
AI-Summary
What this Trial Is About
IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
CONDITIONS
Official Title
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with type 2 diabetes (T2D)
- Receiving primary care within the healthcare system with a visit in the last 24 months (any PCP provider, including APP)
- Evidence of chronic kidney disease (CKD) based on lab tests within the past 2 years, confirmed if not checked within 3 months: UACR >300 mg/g, or eGFR <45 ml/min/1.73 m2, or UACR 630 mg/g with eGFR <60 ml/min/1.73 m2
- Receiving less than 100% guideline-directed medical therapy (GDMT) at baseline, including specified therapies unless contraindicated
You will not qualify if you...
- Type 1 diabetes
- Most recent eGFR less than 20 ml/min/1.73 m2
- Prior kidney transplant
- Autosomal dominant polycystic kidney disease (ADPKD)
- Active pregnancy or plans for conception within 1 year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
University of Alabama
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
Orlando Health
St. Petersburg, Florida, United States, 33701
Actively Recruiting
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
4
Essentia Institute of Rural Health
Duluth, Minnesota, United States, 55805
Actively Recruiting
5
Duke University
Durham, North Carolina, United States, 27707
Actively Recruiting
6
Baylor Scott & White
Temple, Texas, United States, 76508
Actively Recruiting
Research Team
G
Gretchen Sanders, MSN
CONTACT
M
Monica Leyva, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here